Aura Biosciences Files 8-K on Shareholder Vote Matters
Ticker: AURA · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1501796
| Field | Detail |
|---|---|
| Company | Aura Biosciences, INC. (AURA) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: AURA
TL;DR
Aura Bio (AURA) filed an 8-K for shareholder vote matters on 6/17.
AI Summary
Aura Biosciences, Inc. filed an 8-K on June 18, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 17, 2025. The filing details corporate actions and shareholder decisions for the company, which is incorporated in Delaware and headquartered in Boston, Massachusetts.
Why It Matters
This filing indicates that Aura Biosciences held a shareholder meeting or took actions requiring a vote, which is a key governance event for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Aura Biosciences, Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- June 18, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- Boston, Massachusetts (location) — Principal Executive Offices
- 617 500-8864 (phone_number) — Registrant's Telephone Number
FAQ
What specific matters were submitted to a vote of Aura Biosciences' security holders?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided excerpt of the 8-K.
When did the events requiring a vote by security holders take place?
The earliest event reported, which pertains to the submission of matters to a vote of security holders, occurred on June 17, 2025.
What is the principal executive office address for Aura Biosciences, Inc.?
The principal executive offices of Aura Biosciences, Inc. are located at 80 Guest Street, Boston, Massachusetts, 02135.
What is the Commission File Number for Aura Biosciences, Inc.?
The Commission File Number for Aura Biosciences, Inc. is 001-40971.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K being filed?
This Form 8-K is being filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Aura Biosciences, Inc. (AURA).